Pulse Biosciences启动Npulse™技术治疗恶性甲状腺肿瘤可行性研究首批患者入组

美股速递
Mar 12

生物科技公司Pulse Biosciences宣布,其采用Npulse™技术针对恶性甲状腺肿瘤治疗的可行性研究已完成首批患者入组。这项突破性进展标志着该创新疗法正式进入临床验证阶段,为甲状腺癌患者带来新的治疗希望。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10